Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
Matthew M. Nour, Lisa Evans, David Nutt, et al.
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 376

Showing 1-25 of 376 citing articles:

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 504
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
M. Madsen, Patrick M. Fisher, Daniel Burmester, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 7, pp. 1328-1334
Open Access | Times Cited: 376
Predicting Responses to Psychedelics: A Prospective Study
Eline Haijen, Mendel Kaelen, Leor Roseman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 317
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 290
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐Marie Leoutsakos, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1279-1295
Open Access | Times Cited: 263
Psychedelics and connectedness
Robin Carhart‐Harris, David Erritzøe, Eline Haijen, et al.
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 547-550
Closed Access | Times Cited: 234
Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
Frederick S. Barrett, Roland R. Griffiths
Current topics in behavioral neurosciences (2017), pp. 393-430
Open Access | Times Cited: 215
Self unbound: ego dissolution in psychedelic experience
Chris Letheby, Philip Gerrans
Neuroscience of Consciousness (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 210
Psychedelics, Personality and Political Perspectives
Matthew M. Nour, Lisa Evans, Robin Carhart‐Harris
Journal of Psychoactive Drugs (2017) Vol. 49, Iss. 3, pp. 182-191
Open Access | Times Cited: 205
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 2003-2011
Open Access | Times Cited: 202
DMT Models the Near-Death Experience
Christopher Timmermann, Leor Roseman, L. Williams, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 190
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 187
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
Malin V. Uthaug, Kim van Oorsouw, Kim P. C. Kuypers, et al.
Psychopharmacology (2018) Vol. 235, Iss. 10, pp. 2979-2989
Open Access | Times Cited: 186
Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution
Raphaël Millière
Frontiers in Human Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171
Unifying Theories of Psychedelic Drug Effects
Link Ray Swanson
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 165
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Malin V. Uthaug, Rafael Lancelotta, Kim van Oorsouw, et al.
Psychopharmacology (2019) Vol. 236, Iss. 9, pp. 2653-2666
Open Access | Times Cited: 155
A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, et al.
European Neuropsychopharmacology (2020) Vol. 33, pp. 71-80
Open Access | Times Cited: 154
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review
Kwonmok Ko, Gemma Knight, James Rucker, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 153
Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings
Matthias Forstmann, Daniel Alexander Yudkin, Annayah Miranda Beatrice Prosser, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 5, pp. 2338-2346
Open Access | Times Cited: 147
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 139
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Laura Kaertner, Michael B. Steinborn, Hannes Kettner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 108
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top